CERETAS LTD

CERETAS LTD

AASX:CTS
0.90
AUD
-0.04
(-4.26%)
CERETAS LTD
ASX:CTS
(Australian Securities Exchange)

Recent

price

0.90

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Ceretas Ltd. operates as a medical technology company. It develops a device with non-invasive therapeutic ultrasound for the treatment of Alzheimer's disease and other neurodegenerative conditions. The company was founded by Rachel de las Heras, Ryan Laws, and Sam Wetzler in October 2024 and is headquartered in Brisbane, Australia.